I completely agree with you assessment of the disconnect here.
The question I was answering, though, was regarding the potential value after (specifically) MHRA approval. And yes, my understanding of that question was that they were looking for a stock price at that time, basically. So yes, that number is very different from a potential buyout value after global approval, plus the likely advancement of Direct.
Market Data 
Markets 
AI
